Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

 

Dry Mouth and Salivary Glands
Author Biography
Introduction
Xerostomia
Aging and Dry Mouth
Currently Selected Section: Causes of Dry Mouth
Diagnosis
Sjogren's Syndrome
Management of Dry Mouth
Clinical Research
Conclusions

Chapter 27: Dry Mouth and Salivary Gland Dysfunction: Causes of Dry Mouth
        

As noted earlier in this chapter, most complaints of dry mouth are a result of altered salivary gland function. There are other causes, however, including sensory changes in the mouth, often following a CVA or surgical procedure, dehydration, and cognitive alterations. Dry mouth may be a manifestation of anxiety or depression, even without obvious changes in salivary output (Fox et al., 1985).

Drug use
The most common cause of dry mouth complaints is drug use (Sreebny and Schwartz, 1997). Interestingly, xerostomia is a frequent side effect of many pharmaceuticals, in spite of a lack of change in salivary performance. There are examples of drugs which have prominent dry mouth complaints associated with their use which have been found in clinical trials to have no affect on salivary performance (Atkinson et al., 1989; Scully, 2003). Whether this is a result of alterations in some unrecognized salivary component(s) is not known. It is also possible that such drugs may cause other, central alterations that result in the dry mouth symptoms.

However, there are many drugs that do cause reductions in salivary function. Prominent among these are:

  • Antidepressants
  • Antihistaminics
  • Narcotics, and
  • Certain antihypertensives.

Studies have shown that with increasing numbers of drugs used, the incidence and severity of xerostomia increases, as well (Pajukoski et al., 2001; Wu and Ship, 1993). This has a great impact in older populations where prescription drug use is high.

Radiotherapy
Xerostomia is a prominent problem following radiotherapy that includes the salivary glands in the treatment fields. At total delivered doses above 50 Gy, the resultant salivary dysfunction is severe and persistent (Vissink et al., 2003)

Other cancer therapies induce dry mouth complaints (Jensen et al., 2003). During bone marrow or peripheral stem cell transplantation, xerostomia is frequent and may become chronic if GVD develops. Xerostomia is also common with several chemotherapeutic regimens and may persist throughout treatment.

Systemic disease
Systemic disease is another major cause of xerostomia (Wotman and Mandel, 1973). Prominent among conditions with dry mouth symptoms is Sjögren's syndrome, an autoimmune exocrinopathy. Other systemic conditions where dry mouth is a frequent complaint include diabetes, thyroid disorders, connective tissue diseases and cystic fibrosis.


Page 6 of 20
      Previous Section